Sitaglu Met 50/500mg

Sitaglu Met 50/500mg Tablet is a prescribed medication often used to manage type 2 diabetes mellitus. This pharmaceutical product combines two active ingredients, Sitagliptin and Metformin, which work synergistically to control high blood sugar levels.

Yes! You can buy Sitaglu Met 50/500mg Tablet online safely and securely through our website or call us at 03111136337.

The effectiveness of Sitaglu Met 50/500mg tablet in managing type 2 diabetes can vary from person to person. In general, Sitaglu Met 50/500mg tablet can effectively control blood sugar levels as part of a comprehensive diabetes management plan. The combination of Sitagliptin and Metformin works through different mechanisms to improve blood glucose control. 

They can guide you in making necessary adjustments to your diabetes management plan to achieve the best possible outcomes.

The choice to use Sitaglu Met 50/500mg tablet for managing type 2 diabetes is made based on various factors, including the patient's medical history, current health status, and the treatment goals set by the healthcare provider. 

Sitagliptin helps increase insulin secretion and decrease glucose production. At the same time, Metformin reduces glucose production in the liver and improves insulin sensitivity in peripheral tissues. Using them together can offer better glycemic control than using either medication alone.

Sitaglu Met 50/500mg Tablet is a combination medication for treating type 2 diabetes. It contains two active ingredients: Sitagliptin and Metformin. Sitagliptin works by increasing the release of insulin from the pancreas. At the same time, Metformin reduces the glucose the liver produces, and the intestines absorb. Together, they help to control blood sugar levels.

Sitaglu Met 50/500mg Tablet is commonly taken with meals to reduce the risk of stomach upset associated with Metformin. Follow your doctor's instructions on when and how to take the medication. Taking it daily can help maintain consistent blood levels and improve effectiveness.

For Children (1-17)

It is not typically recommended for children unless prescribed by a healthcare provider for a specific medical reason.

For Adults (18-65)

The usual starting dose of Sitaglu Met 50/500mg Tablet is one tablet orally once daily. The maximum recommended daily dose of Sitaglu Met is usually two tablets (100mg Sitagliptin / 1000mg Metformin) per day, taken in divided doses.

For Elders (above 65)

The usual starting dose of Sitaglu Met 50/500mg Tablet for elderly patients is often lower than that for younger adults.

Sitaglu Met 50/500mg Tablet is a combination medication for type 2 diabetes mellitus. It contains two active ingredients: Sitagliptin and Metformin. These two drugs work together through different mechanisms to help improve blood sugar control.

Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. DPP-4 is an enzyme that breaks down incretin hormones in the body, such as GLP-1 (glucagon-like peptide 1). GLP-1 helps regulate blood sugar levels by stimulating insulin release and reducing glucagon secretion. By inhibiting DPP-4, Sitagliptin prolongs the action of GLP-1, leading to increased insulin secretion and decreased glucagon release. 

Metformin is a biguanide medication used for many years to treat type 2 diabetes. It works primarily by reducing the amount of glucose produced by the liver. In the liver, Metformin inhibits gluconeogenesis, which is the process by which the liver creates glucose. By reducing excessive glucose production by the liver, Metformin helps lower fasting blood sugar levels. 

By combining Sitagliptin and Metformin in Sitaglu Met 50/500mg Tablet, the medication addresses multiple aspects of blood sugar regulation, both before and after meals, providing a complementary effect to improve glycemic control in individuals with type 2 diabetes.

The duration of treatment with Sitaglu Met 50/500mg Tablet or any other medication for type 2 diabetes should be determined and monitored by a qualified healthcare provider. The length of treatment can vary depending on individual factors such as the patient's response to the medication, their overall health condition, blood sugar control, and any changes in their medical needs over time. In most cases, Sitaglu Met 50/500mg Tablet is prescribed as a long-term treatment for type 2 diabetes. 

As long as Sitaglu Met controls your blood sugar levels and you are not experiencing any adverse effects, your healthcare provider may recommend continuing with the medication as part of your diabetes management plan.

Sitaglu Met 50/500mg Tablet is not typically recommended for use during pregnancy, especially during the first trimester. While Metformin is considered one of the safer antidiabetic medications during pregnancy, Sitagliptin's safety is less well-established. It's essential to manage blood sugar levels effectively during pregnancy to reduce potential risks to both the mother and the developing fetus. 

Both Sitagliptin and Metformin can pass into breast milk, although the amounts are generally low. The safety of Sitaglu Met 50/500mg Tablet during breastfeeding has not been thoroughly studied.

In both cases (pregnancy and breastfeeding), the healthcare provider will consider the potential benefits of diabetes management with Sitaglu Met against any possible risks to the mother and baby. They will assess your overall health, the severity of your diabetes, and other factors before recommending it.

Sitaglu Met 50/500mg Tablet is used to treat type 2 diabetes mellitus. As with any medication, there are potential side effects that some individuals may experience. Common side effects include headaches, nausea, and gastrointestinal disturbances such as diarrhoea or constipation. Some individuals may also experience hypoglycaemia, or low blood sugar, particularly if they combine this medication with specific other diabetes treatments. Furthermore, long-term use of Metformin, one of the active ingredients in Sitaglu Met, has been associated with vitamin B12 deficiency in some people. Always consult with a healthcare provider for potential side effects and their management.

• Sitaglu Met 50/500mg Tablet can lower blood sugar levels, which may lead to hypoglycemia (low blood sugar). It is essential to be aware of the signs and symptoms of hypoglycemia and know how to treat it if it occurs. Symptoms may include sweating, dizziness, rapid heartbeat, confusion, and weakness.
• Suppose you are scheduled for a radiologic study involving iodinated contrast agents (e.g., CT scan with contrast). In that case, you may need to temporarily stop taking Sitaglu Met 50/500mg Tablet before the procedure. Iodinated contrast agents can affect kidney function and increase the risk of lactic acidosis when used with Metformin.
• Rare cases of pancreatitis (inflammation of the pancreas) have been reported using Sitagliptin. If you experience severe abdominal pain that does not resolve, seek medical attention promptly.
• Sitagliptin, like other DPP-4 inhibitors, has been associated with heart failure in some individuals. If you have a history of heart failure or other heart conditions, use Sitaglu Met 50/500mg Tablet cautiously and be vigilant for signs of worsening heart failure.
• Long-term use of Metformin may lead to reduced absorption of vitamin B12. Your doctor may monitor your B12 levels and consider supplementation if necessary.
• If you are scheduled for surgery or any medical procedure, inform the healthcare provider that you are taking Sitaglu Met 50/500mg Tablet, as the medication may need to be temporarily stopped.
• As previously mentioned, Sitaglu Met is generally not recommended during pregnancy or breastfeeding.